Author Parnetti, Lucilla
-
2012 | Review
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al. (2012)
Biomarkers in Medicine, 6(4) pp. 419-430.
Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46
Details DOI PMID PMC WoS
-
2012 | Journal Article | Research Paper
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Otto, M.; Bowser, R.; Turner, M.; Berry, J.; Brettschneider, J.; Connor, J. & Costa, J. et al. (2012)
Amyotrophic Lateral Sclerosis, 13(1) pp. 1-10. DOI: https://doi.org/10.3109/17482968.2011.627589
Details DOI PMID PMC
-
2012 | Journal Article |
Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
Jesse, S.; Lehnert, S.; Jahn, O.; Parnetti, L.; Soininen, H.; Herukka, S.-K. & Steinacker, P. et al. (2012)
PLoS ONE, 7(11) art. e48783. DOI: https://doi.org/10.1371/journal.pone.0048783
Details DOI
-
2015 | Journal Article
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly
Marizzoni, M.; Antelmi, L.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W.; Wiltfang, J. & Fiedler, U. et al. (2015)
Human Brain Mapping, 36(9) pp. 3516-3527. DOI: https://doi.org/10.1002/hbm.22859
Details DOI
-
2015 | Journal Article
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al. (2015)
Neurobiology of Aging, 36(9) pp. 2587-2596. DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS
-
2016 | Journal Article
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques
Marchitelli, R.; Minati, L.; Marizzoni, M.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W. & Wiltfang, J. et al. (2016)
Human Brain Mapping, 37(6) pp. 2114-2132. DOI: https://doi.org/10.1002/hbm.23157
Details DOI
-
2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI
-
2016 | Journal Article
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a \‘European ADNI study’
Galluzzi, S.; Marizzoni, M.; Babiloni, C.; Albani, D.; Antelmi, L.; Bagnoli, C. & Bartrés-Faz, D. et al. (2016)
Journal of Internal Medicine, 279(6) pp. 576-591. DOI: https://doi.org/10.1111/joim.12482
Details DOI
-
2016 | Journal Article
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects
Albi, A.; Pasternak, O.; Minati, L.; Marizzoni, M.; Bartrés-Faz, D.; Bargalló, N. & Bosch, B. et al. (2016)
Human Brain Mapping, 38(1) pp. 12-26. DOI: https://doi.org/10.1002/hbm.23350
Details DOI
-
2016 | Journal Article
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Simonsen, A. H.; Kuiperij, B.; El-Agnaf, O. M. A.; Engelborghs, S.; Herukka, S.-K.; Parnetti, L. & Rektorova, I. et al. (2016)
Biomarkers in Medicine, 10(1) pp. 19-34. DOI: https://doi.org/10.2217/BMM.14.105
Details DOI PMID PMC WoS
-
2016 | Review
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Mollenhauer, B.; Parnetti, L.; Rektorova, I.; Kramberger, M. G.; Pikkarainen, M.; Schulz-Schaeffer, W. J.& Aarsland, D. et al. (2016)
Journal of Neurochemistry, 139 pp. 290-317.
Wiley-blackwell. DOI: https://doi.org/10.1111/jnc.13390
Details DOI PMID PMC WoS
-
2017 | Journal Article
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)
Nathan, P. J.; Lim, Y. Y.; Abbott, R.; Galluzzi, S.; Marizzoni, M.; Babiloni, C. & Albani, D. et al. (2017)
Neurobiology of Aging, 53 pp. 1-10. DOI: https://doi.org/10.1016/j.neurobiolaging.2017.01.013
Details DOI
-
2017 | Journal Article |
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
Chiasserini, D.; Biscetti, L.; Eusebi, P.; Salvadori, N.; Frattini, G.; Simoni, S. & De Roeck, N. et al. (2017)
Alzheimer's Research & Therapy, 9(1). DOI: https://doi.org/10.1186/s13195-017-0276-4
Details DOI
-
2018 | Journal Article
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al. (2018)
The World Journal of Biological Psychiatry, 19(4) pp. 244-328. DOI: https://doi.org/10.1080/15622975.2017.1375556
Details DOI
-
2018 | Journal Article |
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P. & Lleó, A. et al. (2018)
Alzheimer's Research & Therapy, 10(1). DOI: https://doi.org/10.1186/s13195-018-0359-x
Details DOI
-
2019 | Journal Article
Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity
Jovicich, J.; Babiloni, C.; Ferrari, C.; Marizzoni, M.; Moretti, D. V.; Del Percio, C. & Lizio, R. et al. (2019)
Journal of Alzheimer's Disease, 69(1) pp. 15-35. DOI: https://doi.org/10.3233/JAD-180158
Details DOI
-
2019 | Journal Article
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
Albani, D.; Marizzoni, M.; Ferrari, C.; Fusco, F.; Boeri, L.; Raimondi, I. & Jovicich, J. et al. (2019)
Journal of Alzheimer's Disease, 69(1) pp. 37-48. DOI: https://doi.org/10.3233/JAD-180321
Details DOI
-
2019 | Journal Article
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease
Marizzoni, M.; Ferrari, C.; Macis, A.; Jovicich, J.; Albani, D.; Babiloni, C. & Cavaliere, L. et al. (2019)
Journal of Alzheimer's Disease, 69(1) pp. 49-58. DOI: https://doi.org/10.3233/JAD-181016
Details DOI
-
2019 | Journal Article
Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?
Lleó, A.; Parnetti, L.; Belbin, O. & Wiltfang, J. (2019)
Clinica Chimica Acta, 491 pp. 81-84. DOI: https://doi.org/10.1016/j.cca.2019.01.019
Details DOI
-
2019 | Journal Article
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers
Marizzoni, M.; Ferrari, C.; Jovicich, J.; Albani, D.; Babiloni, C.; Cavaliere, L. & Didic, M. et al. (2019)
Journal of Alzheimer's Disease, 69(1) pp. 3-14. DOI: https://doi.org/10.3233/JAD-180152
Details DOI
-
2019 | Journal Article
CSF and blood biomarkers for Parkinson's disease
Parnetti, L.; Gaetani, L.; Eusebi, P.; Paciotti, S.; Hansson, O.; El-Agnaf, O. & Mollenhauer, B. et al. (2019)
The Lancet Neurology, 18(6) pp. 573-586. DOI: https://doi.org/10.1016/S1474-4422(19)30024-9
Details DOI
-
2020 | Journal Article
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Marizzoni, M.; Ferrari, C.; Babiloni, C.; Albani, D.; Barkhof, F.; Cavaliere, L. & Didic, M. et al. (2020)
Neurobiology of Aging, 89 pp. 55-62. DOI: https://doi.org/10.1016/j.neurobiolaging.2019.12.019
Details DOI
-
2020 | Journal Article
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al. (2020)
PLoS Medicine, 17(8) pp. e1003289. DOI: https://doi.org/10.1371/journal.pmed.1003289
Details DOI
-
2021 | Journal Article
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study
Ribaldi, F.; Altomare, D.; Jovicich, J.; Ferrari, C.; Picco, A.; Pizzini, F. B. & Soricelli, A. et al. (2021)
Magnetic Resonance Imaging, 76 pp. 108-115. DOI: https://doi.org/10.1016/j.mri.2020.11.008
Details DOI